US Alzheimer's Disease Diagnostic Market Research Report Forecast to 2040
US Alzheimer's Disease Diagnostic market is anticipated to register a notable CAGR of 7.92% during the review period. Alzheimer's disease, often referred to simply as Alzheimer's, is a progressive and degenerative brain disorder that primarily affects cognitive functions, especially memory, thinking, and behavior. It is the most common cause of dementia in older adults. The disease is characterized by the accumulation of abnormal protein deposits, including beta-amyloid plaques and tau tangles, in the brain, which lead to the death of brain cells and the disruption of neural pathways.
The US Alzheimer’s disease diagnostic market is emerging due to Increasing prevalence of Alzheimer’s disease, growing aging population and raising awareness about Alzheimer's disease. Additionally, growth of telemedicine and remote monitoring technologies presents opportunities for Alzheimer's disease diagnostics market in the future. However, the high cost of diagnosis might hamper the market's growth in the forecast period.
Market Segmentation
Based on product, the market has been segmented into reagents & kits and equipment & accessories.
Based on the type, the market has been segmented into early onset Alzheimer disease and late onset Alzheimer disease.
Based on test type, the US Alzheimer’s disease diagnostic market has been segmented into genetic testing, brain imaging, neurological exams, mini mental state exam (MMSE), and others.
Based on end user, the US Alzheimer’s disease diagnostic market has been segmented into hospitals, and diagnostic laboratories, and others.
Major Players
The Key market players in the US Alzheimer's Disease Diagnostic market are Siemens, F. Hoffmann-La Roche Ltd, GE Healthcare, Fujirebio, QYNAPSE, and Koninklijke Philips N.V.
Companies Mentioned
Siemens F. Hoffmann-La Roche Ltd GE Healthcare Fujirebio QYNAPSE and Koninklijke Philips N.V.
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Technique
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence Of Alzheimer’s Disease
4.2.2 Growing Aging Population
4.2.3 Raising Awareness About Alzheimer's Disease
4.3 Restraints
4.3.1 High Cost Of Diagnosis
4.4 Opportunity
4.4.1 Growth Of Telemedicine And Remote Monitoring Technologies Presents Opportunities For Alzheimer's Disease Diagnostics Market
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D And Designing
5.1.2 Manufacturing
5.1.3 Distribution, Marketing, And Sales
5.1.4 Post-sales Monitoring
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power Of Suppliers
5.2.2 Bargaining Power Of Buyers
5.2.3 Threat Of New Entrants
5.2.4 Threat Of Substitutes
5.2.5 Intensity Of Rivalry
5.3 Impact Analysis Of Covid-19 On Alzheimer’s Disease Diagnostic Market
5.3.1 Overview
5.4 Market Key Trends For Alzheimer's Disease Diagnostic Market
5.5 Analysis Of Intellectual Property (Ip) & Startups
5.5.1 Intellectual Property (Ip)
5.5.2 Startups
5.6 Changes In Healthcare Policies
5.7 Clinical Diagnosis Of Alzheimer's Disease
5.8 Provider And Payer Coverage Policies For Alzheimer's Disease Diagnostics
5.9 Alzheimer's Disease Pre-diagnosis And Diagnosis In The Us
5.10 Alzheimer's Disease Treatment/ Disease Management And Monitoring
6 Us Alzheimer’s Disease Diagnostic Market, By Product
6.1 Overview
7 Us Alzheimer’s Disease Diagnostic Market, By Type
7.1 Overview
8 Us Alzheimer’s Disease Diagnostic Market, By Test Type
8.1 Overview
9 Us Alzheimer’s Disease Diagnostic Market, By End User
9.1 Overview
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2022
10.3 Competitor Dashboard
10.4 Public Players Stock Summary
10.5 Comparative Analysis: Key Players Finanical
10.6 Key Developments & Growth Strategies
10.6.1 Product Launch/Product Approval
10.6.1 Partnership
11 Company Profiles
11.1 Siemens
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategies
11.2 F. Hoffmann-la Roche Ltd
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategies
11.3 Ge Healthcare
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Koninklijke Philips N.V.
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategies
11.5 Bmg Labtech
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offered
11.5.4 Key Developments
11.5.5 Key Strategies
11.6 Bioassay Systems
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Swot Analysis
11.6.6 Key Strategies
11.7 Sciencell Research Laboratories, Inc
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offered
11.7.4 Key Developments
11.7.5 Key Strategies
11.8 Fujirebio
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offered
11.8.4 Key Developments
11.8.5 Key Strategies
11.9 Quanterix
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offered
11.9.4 Key Developments
11.9.5 Key Strategies
11.10 Qynapse
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offered
11.10.4 Key Developments
11.10.5 Key Strategies
12 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Us Alzheimer’s Disease Diagnostic Market, By Product, 2019–2040 (Usd Million)
Table 3 Us Alzheimer’s Disease Diagnostic Market, By Type, 2019–2040 (Usd Million)
Table 4 Us Alzheimer’s Disease Diagnostic Market, By Test Type, 2019–2040 (Usd Million)
Table 5 Us Alzheimer’s Disease Diagnostic Market, For Brain Imaging, By Type, 2019–2040 (Usd Million)
Table 6 Us Alzheimer’s Disease Diagnostic Market, By End User, 2019–2040 (Usd Million)